BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Veru
VERU
$37.4M
| $32.9M | ﹤0.01% |
408,262
+15,685
| +4% | +$1.38M |
|
2977
UBS Group
UBS
$176B
| $32.9M | ﹤0.01% |
2,147,502
+116,892
| +6% | +$1.85M |
|
2978
Sierra Bancorp
BSRR
$528M
| $32.9M | ﹤0.01% |
1,293,059
-81,459
| -6% | -$2.2M |
|
2979
BioXcel Therapeutics
BTAI
$26M
| $32.9M | ﹤0.01% |
70,775
+4,893
| +7% | +$2.67M |
|
2980
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.24B
| $32.8M | ﹤0.01% |
848,975
+465,795
| +122% | +$18.3M |
|
2981
Immunovant
IMVT
$8.11B
| $32.8M | ﹤0.01% |
3,102,787
-582,229
| -16% | -$8.13M |
|
2982
Miller Industries
MLR
$579M
| $32.8M | ﹤0.01% |
830,709
-39,196
| -5% | -$1.67M |
|
2983
Global Industrial
GIC
$1.48B
| $32.6M | ﹤0.01% |
888,493
-71,147
| -7% | -$2.71M |
|
|
REVG
2984
DELISTED
REV Group
REVG
| $32.6M | ﹤0.01% |
2,077,904
-49,580
| -2% | -$898K |
|
|
LORL
2985
DELISTED
Loral Space and Communications, Inc.
LORL
| $32.6M | ﹤0.01% |
838,975
-129,526
| -13% | -$4.92M |
|
2986
Canadian Imperial Bank of Commerce
CM
$108B
| $32.6M | ﹤0.01% |
572,160
+23,280
| +4% | +$1.28M |
|
2987
Playboy Inc
PLBY
$134M
| $32.6M | ﹤0.01% |
837,253
+499,943
| +148% | +$21.1M |
|
2988
Equity Bancshares
EQBK
$1.06B
| $32.4M | ﹤0.01% |
1,063,687
-131,379
| -11% | -$4.02M |
|
2989
InnovAge Holding
INNV
$1.51B
| $32.3M | ﹤0.01% |
1,515,508
+449,784
| +42% | +$10.3M |
|
2990
Wheaton Precious Metals
WPM
$55.8B
| $32.3M | ﹤0.01% |
732,590
+134,172
| +22% | +$5.97M |
|
2991
American Superconductor
AMSC
$1.6B
| $32.3M | ﹤0.01% |
1,856,405
-164,192
| -8% | -$2.63M |
|
2992
Bank First Corp
BFC
$1.73B
| $32.2M | ﹤0.01% |
461,413
-7,355
| -2% | -$525K |
|
|
BNFT
2993
DELISTED
Benefitfocus, Inc.
BNFT
| $32.2M | ﹤0.01% |
2,283,151
-134,234
| -6% | -$1.89M |
|
2994
Avita Medical
RCEL
$142M
| $32.2M | ﹤0.01% |
1,568,083
+1,290,956
| +466% | +$25.4M |
|
2995
FRP Holdings
FRPH
$421M
| $32.2M | ﹤0.01% |
1,155,576
-16,156
| -1% | -$447K |
|
2996
CytomX Therapeutics
CTMX
$723M
| $32.2M | ﹤0.01% |
5,080,623
-108,082
| -2% | -$842K |
|
|
CCRV
2997
DELISTED
iShares Commodity Curve Carry Strategy ETF
CCRV
| $32M | ﹤0.01% |
1,250,000
| – | – |
|
2998
Rafael Holdings
RFL
$106M
| $32M | ﹤0.01% |
634,962
-67,630
| -10% | -$2.95M |
|
2999
Omega Flex
OFLX
$307M
| $31.9M | ﹤0.01% |
217,683
+17,870
| +9% | +$2.7M |
|
|
VERV
3000
DELISTED
Verve Therapeutics
VERV
| $31.9M | ﹤0.01% |
+529,924
| New | +$22M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.